Cardiorenal biomarkers: one step closer.
作者信息
Chen Xiao-Jun, Lerman Amir, Lerman Lilach O
机构信息
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
出版信息
J Lab Precis Med. 2017 May;2. doi: 10.21037/jlpm.2017.05.04.
Abstract
摘要
相似文献
1
Cardiorenal biomarkers: one step closer.心肾生物标志物：又迈进了一步。
J Lab Precis Med. 2017 May;2. doi: 10.21037/jlpm.2017.05.04.
2
Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.心肾综合征中的生物标志物及对新型治疗方法的潜在见解
Front Cardiovasc Med. 2022 May 20;9:868658. doi: 10.3389/fcvm.2022.868658. eCollection 2022.
3
The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers.心脏肾综合征：可溶性生物标志物的机制见解和预后判断。
Curr Cardiol Rep. 2020 Aug 8;22(10):114. doi: 10.1007/s11886-020-01360-8.
4
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR).背景和设计：一项由研究者发起的、多中心、前瞻性、安慰剂对照、双盲、随机临床试验，旨在评估非奈利酮对 2 型糖尿病和慢性肾脏病患者血管僵硬和心肾生物标志物的影响（FIVE-STAR）。
Cardiovasc Diabetol. 2023 Jul 31;22(1):194. doi: 10.1186/s12933-023-01928-y.
5
Novel renal biomarkers to assess cardiorenal syndrome.用于评估心肾综合征的新型肾脏生物标志物。
Curr Heart Fail Rep. 2014 Dec;11(4):485-99. doi: 10.1007/s11897-014-0226-4.
6
[Biomarkers of cardiorenal syndrome].[心肾综合征的生物标志物]
Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):409-18. doi: 10.1684/abc.2013.0877.
7
Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong.心肾综合征：完善对一种出错的复杂共生关系的定义。
Intensive Care Med. 2008 May;34(5):957-62. doi: 10.1007/s00134-008-1017-8. Epub 2008 Feb 5.
8
Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes.多种生物标志物之间的相互作用可能有助于急性或慢性心肾综合征的快速识别。
Cardiorenal Med. 2016 Feb;6(2):99-107. doi: 10.1159/000437309. Epub 2015 Nov 11.
9
Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk.超越心肾综合征：肾脏与心脏相互作用的病理生理学方法及生物标志物
Diagnostics (Basel). 2022 Mar 22;12(4):773. doi: 10.3390/diagnostics12040773.
10
Cardiorenal Protective Effect of Costunolide against Doxorubicin-Induced Toxicity in Rats by Modulating Oxidative Stress, Inflammation and Apoptosis.穿心莲内酯通过调节氧化应激、炎症和细胞凋亡对多柔比星诱导的大鼠心肝毒性的保护作用。
Molecules. 2022 Mar 25;27(7):2122. doi: 10.3390/molecules27072122.
本文引用的文献
1
High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study.胸痛合并肾病患者的高敏肌钙蛋白水平：一项多中心注册研究——TROPIC研究
Cardiol J. 2017;24(2):139-150. doi: 10.5603/CJ.a2017.0025. Epub 2017 Mar 10.
2
Estimated Glomerular Filtration Rate and Albuminuria Are Associated with Biomarkers of Cardiac Injury in a Population-Based Cohort Study: The Maastricht Study.基于人群队列研究：马斯特里赫特研究中，估算肾小球滤过率和白蛋白尿与心脏损伤生物标志物相关。
Clin Chem. 2017 Apr;63(4):887-897. doi: 10.1373/clinchem.2016.266031. Epub 2017 Feb 17.
3
Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages.利用高敏心肌肌钙蛋白 T 提高不同慢性肾脏病分期急性心肌梗死的诊断准确性。
Sci Rep. 2017 Feb 1;7:41350. doi: 10.1038/srep41350.
4
Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.心肌肌钙蛋白 T：终末期肾病患者的小分子物质比急性心肌梗死发作后少。
Clin Chem. 2017 Mar;63(3):683-690. doi: 10.1373/clinchem.2016.261644. Epub 2017 Jan 10.
5
Association of Increasing GFR with Change in Albuminuria in the General Population.普通人群中肾小球滤过率升高与蛋白尿变化的关联。
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2186-2194. doi: 10.2215/CJN.04940516. Epub 2016 Sep 28.
6
Serum Troponin I Level for Diagnosis of Acute Coronary Syndrome in Patients with Chronic Kidney Disease.血清肌钙蛋白I水平用于慢性肾脏病患者急性冠状动脉综合征的诊断
Iran J Kidney Dis. 2016 Jan;10(1):11-6.
7
Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease.胸痛且冠状动脉无阻塞的患者中心血管功能障碍的患病率。
JACC Cardiovasc Interv. 2015 Sep;8(11):1445-1453. doi: 10.1016/j.jcin.2015.06.017.
8
Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency.高敏肌钙蛋白 T 在肾功能不全患者中的诊断性能。
Am J Cardiol. 2013 Dec 15;112(12):1968-72. doi: 10.1016/j.amjcard.2013.08.028. Epub 2013 Sep 30.
9
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.B 型利钠肽与氨基末端 pro-B 型利钠肽：在肾功能受损患者中选择最佳心力衰竭标志物。
BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.
10
Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.在非缺血性心力衰竭患者中，冠状动脉微血管功能障碍和舒张负荷与高敏检测的心肌肌钙蛋白 T 释放相关。
J Am Coll Cardiol. 2013 Aug 13;62(7):632-40. doi: 10.1016/j.jacc.2013.03.065. Epub 2013 May 1.
Zotero 插件